A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
dc.contributor.author | Liu C. | |
dc.contributor.author | Zhou D. | |
dc.contributor.author | Dijokaite-Guraliuc A. | |
dc.contributor.author | Supasa P. | |
dc.contributor.author | Duyvesteyn H.M.E. | |
dc.contributor.author | Ginn H.M. | |
dc.contributor.author | Selvaraj M. | |
dc.contributor.author | Mentzer A.J. | |
dc.contributor.author | Das R. | |
dc.contributor.author | de Silva T.I. | |
dc.contributor.author | Ritter T.G. | |
dc.contributor.author | Plowright M. | |
dc.contributor.author | Newman T.A.H. | |
dc.contributor.author | Stafford L. | |
dc.contributor.author | Kronsteiner B. | |
dc.contributor.author | Temperton N. | |
dc.contributor.author | Lui Y. | |
dc.contributor.author | Fellermeyer M. | |
dc.contributor.author | Goulder P. | |
dc.contributor.author | Klenerman P. | |
dc.contributor.author | Dunachie S.J. | |
dc.contributor.author | Barton M.I. | |
dc.contributor.author | Kutuzov M.A. | |
dc.contributor.author | Dushek O. | |
dc.contributor.author | Fry E.E. | |
dc.contributor.author | Mongkolsapaya J. | |
dc.contributor.author | Ren J. | |
dc.contributor.author | Stuart D.I. | |
dc.contributor.author | Screaton G.R. | |
dc.contributor.correspondence | Liu C. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2024-05-24T18:38:59Z | |
dc.date.available | 2024-05-24T18:38:59Z | |
dc.date.issued | 2024-05-21 | |
dc.description.abstract | BA.2.86, a recently described sublineage of SARS-CoV-2 Omicron, contains many mutations in the spike gene. It appears to have originated from BA.2 and is distinct from the XBB variants responsible for many infections in 2023. The global spread and plethora of mutations in BA.2.86 has caused concern that it may possess greater immune-evasive potential, leading to a new wave of infection. Here, we examine the ability of BA.2.86 to evade the antibody response to infection using a panel of vaccinated or naturally infected sera and find that it shows marginally less immune evasion than XBB.1.5. We locate BA.2.86 in the antigenic landscape of recent variants and look at its ability to escape panels of potent monoclonal antibodies generated against contemporary SARS-CoV-2 infections. We demonstrate, and provide a structural explanation for, increased affinity of BA.2.86 to ACE2, which may increase transmissibility. | |
dc.identifier.citation | Cell Reports Medicine Vol.5 No.5 (2024) | |
dc.identifier.doi | 10.1016/j.xcrm.2024.101553 | |
dc.identifier.eissn | 26663791 | |
dc.identifier.pmid | 38723626 | |
dc.identifier.scopus | 2-s2.0-85193448044 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/98457 | |
dc.rights.holder | SCOPUS | |
dc.subject | Biochemistry, Genetics and Molecular Biology | |
dc.title | A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85193448044&origin=inward | |
oaire.citation.issue | 5 | |
oaire.citation.title | Cell Reports Medicine | |
oaire.citation.volume | 5 | |
oairecerif.author.affiliation | Mahidol Oxford Tropical Medicine Research Unit | |
oairecerif.author.affiliation | NIHR Oxford Biomedical Research Centre | |
oairecerif.author.affiliation | Medway School of Pharmacy | |
oairecerif.author.affiliation | Diamond Light Source | |
oairecerif.author.affiliation | University of Oxford | |
oairecerif.author.affiliation | Sheffield Teaching Hospitals NHS Foundation Trust | |
oairecerif.author.affiliation | Sir William Dunn School of Pathology | |
oairecerif.author.affiliation | Nuffield Department of Medicine | |
oairecerif.author.affiliation | University of Oxford Medical Sciences Division | |
oairecerif.author.affiliation | The University of Sheffield | |
oairecerif.author.affiliation | Centre for Free-Electron Laser Science |